Related Experiment Videos
Carbamazepine toxicity induced by concurrent erythromycin therapy
Archives of Neurology
|February 1, 1985
Summary
Concurrent use of erythromycin stearate with carbamazepine can cause dangerous carbamazepine toxicity, including syndrome of inappropriate antidiuretic hormone secretion. This drug interaction necessitates careful patient monitoring and potential dose adjustments.
Area of Science:
- Pharmacology
- Clinical Toxicology
- Internal Medicine
Background:
- Carbamazepine is a widely prescribed antiepileptic drug.
- Erythromycin is a common antibiotic.
- Drug interactions can significantly alter therapeutic outcomes.
Observation:
- A 41-year-old woman experienced carbamazepine toxicity.
- The toxicity occurred during concurrent administration of erythromycin stearate.
- Symptoms included the syndrome of inappropriate antidiuretic hormone secretion.
Findings:
- Erythromycin stearate potentiates carbamazepine levels.
- This interaction can lead to severe carbamazepine toxicity.
- The mechanism involves altered drug metabolism.
Implications:
- Clinicians must be aware of this significant drug interaction.
- Concurrent prescribing requires careful monitoring for toxicity.
- Dosage adjustments may be necessary to ensure patient safety.